Nath Bio-Genes (India) Limited (NATHBIOGEN.NS)
INR 167.98
(0.33%)
INR 167.98
(0.33%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 554.12 Million INR | 0.1% |
| 2022 | 1.2 Billion INR | 0.91% |
| 2021 | 1.19 Billion INR | 12.13% |
| 2020 | 1.06 Billion INR | 8.09% |
| 2019 | 987.89 Million INR | 22.84% |
| 2018 | 804.23 Million INR | 23.17% |
| 2017 | 652.97 Million INR | -9.29% |
| 2016 | 719.87 Million INR | -16.41% |
| 2015 | 861.16 Million INR | -10.85% |
| 2014 | 965.92 Million INR | -3.39% |
| 2013 | 999.79 Million INR | 45.86% |
| 2012 | 685.43 Million INR | 11.69% |
| 2011 | 613.69 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 776.85 Million INR | 89.49% |
| 2024 Q2 | 157.38 Million INR | -92.3% |
| 2023 Q1 | 764.51 Million INR | 203.63% |
| 2023 FY | 1.2 Billion INR | 0.1% |
| 2023 Q3 | 127.12 Million INR | -6.36% |
| 2023 Q2 | 135.76 Million INR | -82.24% |
| 2023 Q4 | 409.97 Million INR | 222.5% |
| 2022 Q4 | 251.79 Million INR | 133.83% |
| 2022 Q2 | 125.1 Million INR | -82.65% |
| 2022 FY | 1.2 Billion INR | 0.91% |
| 2022 Q1 | 721.24 Million INR | 69.37% |
| 2022 Q3 | 107.68 Million INR | -13.93% |
| 2021 Q1 | 519.78 Million INR | 139.69% |
| 2021 Q4 | 425.83 Million INR | 381.92% |
| 2021 FY | 1.19 Billion INR | 12.13% |
| 2021 Q3 | 88.36 Million INR | 5.99% |
| 2021 Q2 | 83.37 Million INR | -83.96% |
| 2020 FY | 1.06 Billion INR | 8.09% |
| 2020 Q4 | 216.85 Million INR | 20.54% |
| 2020 Q1 | 519.83 Million INR | 129.53% |
| 2020 Q2 | 151.24 Million INR | -70.91% |
| 2020 Q3 | 179.91 Million INR | 18.95% |
| 2019 Q4 | 226.48 Million INR | 35.3% |
| 2019 Q3 | 167.39 Million INR | 8.9% |
| 2019 FY | 987.89 Million INR | 22.84% |
| 2019 Q1 | 443.56 Million INR | 142.33% |
| 2019 Q2 | 153.7 Million INR | -65.35% |
| 2018 Q3 | 137.25 Million INR | -13.46% |
| 2018 Q4 | 183.03 Million INR | 33.35% |
| 2018 FY | 804.23 Million INR | 23.17% |
| 2018 Q1 | 333.5 Million INR | 36.16% |
| 2018 Q2 | 158.6 Million INR | -52.44% |
| 2017 Q4 | 244.92 Million INR | 120.05% |
| 2017 FY | 652.97 Million INR | -9.29% |
| 2017 Q1 | 248.81 Million INR | -14.76% |
| 2017 Q2 | 52.57 Million INR | -78.87% |
| 2017 Q3 | 111.3 Million INR | 111.72% |
| 2016 Q1 | 281.51 Million INR | 4.21% |
| 2016 Q3 | 79.19 Million INR | 1.34% |
| 2016 Q4 | 291.9 Million INR | 268.6% |
| 2016 Q2 | 78.14 Million INR | -72.24% |
| 2016 FY | 719.87 Million INR | -16.41% |
| 2015 Q3 | 139.32 Million INR | 138.39% |
| 2015 Q4 | 270.14 Million INR | 93.89% |
| 2015 Q2 | 58.44 Million INR | -85.72% |
| 2015 Q1 | 409.14 Million INR | 60.15% |
| 2015 FY | 861.16 Million INR | -10.85% |
| 2014 FY | 965.92 Million INR | -3.39% |
| 2014 Q4 | 255.46 Million INR | 71.02% |
| 2014 Q3 | 149.38 Million INR | 23.65% |
| 2014 Q2 | 120.81 Million INR | -75.85% |
| 2014 Q1 | 500.26 Million INR | 108.62% |
| 2013 Q4 | 239.8 Million INR | 13.16% |
| 2013 FY | 999.79 Million INR | 45.86% |
| 2013 Q1 | 312.94 Million INR | 75.93% |
| 2013 Q2 | 235.12 Million INR | -24.87% |
| 2013 Q3 | 211.91 Million INR | -9.87% |
| 2012 Q1 | 197.31 Million INR | 0.0% |
| 2012 Q3 | 98.96 Million INR | -29.95% |
| 2012 Q4 | 177.88 Million INR | 79.75% |
| 2012 Q2 | 141.27 Million INR | -28.4% |
| 2012 FY | 685.43 Million INR | 11.69% |
| 2011 FY | 613.69 Million INR | 0.0% |